January 27, 2023
Sector changes, evolves and disintegrates as many wait for an algorithmic bromide
Pre-open Indications: 3 Negative Indications and 2 Positive Indication
I write this blog/newsletter to inform investors with facts and supporting numbers focused on what they need to hear that others won’t say or write about - truth! Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
Join me … in the NO spin zone.
The 8:00 a.m. edition
January 25, 2023
PGEN closed up (Tuesday) +$0.02 to $2.19 with a market response to the S-3 of -$0.60 or -27.625% to $1.59
Also granted the underwriters a 30-day option to purchase up to an additional $11.25 M of its common stock.
January 27, 2023
Big economic number’s drops and pops day as sector luckily moves to the upside
Pre-Open Indication: 2 Hits and 3 MISS
The Biostage (OTCQB: BSTG) Chronicles: four (4) sessions in a row with 2K shares traded each session, the pump (volume) and promote (share price) this week to keep the value up; after Monday’s -$0.09 and two (2) NO volume days. Shouldn’t the SEC be monitoring? Should U.S. investors trust any forthcoming offering?
I write this blog/newsletter to inform investors with facts and supporting numbers focused on what they need to hear that others won’t say or write about - truth!
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors! Join me … in the NO spin zone.
January 25, 2023
PGEN closed up (Tuesday) +$0.02 to $2.19 with a market response to the S-3 of -$0.60 or -27.625% to $1.59 Also granted the underwriters a 30-day option to purchase up to an additional $11.25 M of its common stock.
January 24, 2023
Definitive agreement to sell approximately 2.1 million shares of its Series B Convertible Preferred Stock to affiliates of BVF Partners L.P. of $60 million in two tranches VSTM closed up +$0.02 to $0.61 with a negative -$0.01 or -1.66% aftermarket - so far and STILL de-listed from Nasdaq
January 18, 2023
BLUE priced at $6.00, the aftermarket is up +$0.12 or +2.07% BLUE also intends to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of its common stock to be sold in the offering.